SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022920
Filing Date
2022-11-08
Accepted
2022-11-08 08:02:27
Documents
63
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-20220930.htm   iXBRL 10-Q 2538981
2 EX-31.1 pmvp-ex31_1.htm EX-31.1 21106
3 EX-31.2 pmvp-ex31_2.htm EX-31.2 21075
4 EX-32.1 pmvp-ex32_1.htm EX-32.1 12197
5 EX-32.2 pmvp-ex32_2.htm EX-32.2 12824
  Complete submission text file 0000950170-22-022920.txt   8615086

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pmvp-20220930_pre.xml EX-101.PRE 273345
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pmvp-20220930.xsd EX-101.SCH 47162
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pmvp-20220930_cal.xml EX-101.CAL 40703
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pmvp-20220930_def.xml EX-101.DEF 118996
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pmvp-20220930_lab.xml EX-101.LAB 387550
57 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20220930_htm.xml XML 1816665
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 221367321
SIC: 2834 Pharmaceutical Preparations